2001 - 2010 of 4301 Drugs
Jardiance (empagliflozin tablets)
Jardiance (empagliflozin) is an inhibitor of the sodium-glucose co-transporter 2 (SGLT2) used as an adjunct to diet and exercise to improve glycemic control in adults with type 2 diabetes mellitus. Jardiance is also indicated to reduce the risk of cardiovascular death in adult patients with type 2 diabetes mellitus and cardiovascular disease.
Trijardy XR (empagliflozin, linagliptin, and metformin hydrochloride extended-release tablets)
Trijardy XR (empagliflozin, linagliptin, and metformin hydrochloride extended-release tablets) is a combination of a sodium-glucose co-transporter 2 (SGLT2) inhibitor, a dipeptidyl peptidase-4 (DPP-4) inhibitor, and a biguanide, indicated as an adjunct to diet and exercise to improve glycemic control in adults with type 2 diabetes mellitus. Empagliflozin is indicated to reduce the risk of cardiovascular death in adults with type 2 diabetes mellitus and established cardiovascular disease.
Empaveli (pegcetacoplan injection, for subcutaneous use)
Empaveli (pegcetacoplan) is a complement inhibitor used to treat adult patients with paroxysmal nocturnal hemoglobinuria (PNH).
Emsam (selegiline transdermal system)
Emsam (selegiline transdermal system) is an antidepressant used to treat major depressive disorder in adults.
Emtriva (emtricitabine)
Emtriva (emtricitabine) is an antiviral medication used to treat the human immunodeficiency virus (HIV) which causes the acquired immunodeficiency syndrome (AIDS). Emtriva is not a cure for HIV or AIDS.
Truvada (emtricitabine tenofovir df)
Truvada (emtricitabine/tenofovir disoproxil fumarate) is a combination of antiviral drugs used to treat HIV, which causes acquired immunodeficiency syndrome (AIDS). Truvada is not a cure for HIV or AIDS.
Odefsey (emtricitabine, rilpivirine, and tenofovir alafenamide fixed-dose combination tablets)
Odefsey (emtricitabine, rilpivirine, and tenofovir alafenamide) is a combination of two HIV nucleoside analog reverse transcriptase inhibitors (NRTIs) and a non-nucleoside reverse transcriptase inhibitor (NNRTI) indicated as a complete regimen for the treatment of HIV-1 infection in patients 12 years of age and older as initial therapy in those with no antiretroviral treatment history with HIV-1 RNA less than or equal to 100,000 copies per mL; or to replace a stable antiretroviral regimen in those who are virologically-suppressed (HIV-1 RNA less than 50 copies per mL) for at least six months with no history of treatment failure and no known substitutions associated with resistance to the individual components of Odefsey.
Emverm (mebendazole chewable tablet, usp)
Emverm (mebendazole) Chewable Tablet is a broad-spectrum anthelmintic indicated for the treatment of Enterobius vermicularis (pinworm), Trichuris trichiura (whipworm), Ascaris lumbricoides (common roundworm), Ancylostoma duodenale (common hookworm), Necator americanus (American hookworm) in single or mixed infections.
Vasotec (enalapril)
Vasotec (enalapril maleate) is an ACE (angiotensin converting enzyme) inhibitor used to treat high blood pressure (hypertension), congestive heart failure, kidney problems caused by diabetes, and to improve survival after a heart attack. Vasotec is available in generic form.
Lexxel (enalapril maleate-felodipine)
Lexxel (enalapril maleate-felodipine ER) is a combination ACE inhibitor and calcium channel blocker used to treat high blood pressure (hypertension). Lexxel is usually given after other blood pressure medications have been tried without successful treatment of hypertension. The brand name Lexxel is discontinued, but generic versions may be available.